Integra Lifesciences Holdings (IART) FCF Margin (2009 - 2026)
Integra Lifesciences Holdings (IART) posted FCF Margin of 2.51% for Q2 2026, up 294.69% sequentially from 1.29% in Q1 2026, and up 521.0% YoY from 0.4% in Q2 2025.
Integra Lifesciences Holdings (IART) FCF Margin (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported FCF Margin for 18 years, with the latest figure at 2.51% in Q2 2026.
- Quarterly FCF Margin rose 521.0% year-over-year to 2.51% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 1.57% (up 387.0% YoY) and the FY2025 annual result came in at 1.9%, down 345.0% from the prior year.
- FCF Margin climbed to 2.51% in Q2 2026 per IART's latest filing, from 1.29% in the prior quarter.
- Over five years, FCF Margin peaked at 17.81% in Q4 2022 and troughed at 10.5% in Q1 2025.
- A 5-year average of 4.13% and a median of 3.3% in 2023 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2023 and 2026: FCF Margin sank 1178 bps in 2023, then soared 921 bps in 2026.
- Over 5 years, FCF Margin stood at 17.81% in 2022, then tumbled by 52 bps to 8.62% in 2023, then tumbled by 45 bps to 4.78% in 2024, then plunged by 126 bps to 1.24% in 2025, then jumped by 302 bps to 2.51% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 2.51%, 1.29%, and 1.24% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 18.73% |
| 10 | Integra Lifesciences Holdings | 1.32 Bn | 1.05 Bn | 219.74 Mn | 2.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.51% |
| Mar 31, 2026 | -1.29% |
| Dec 31, 2025 | -1.24% |
| Sep 30, 2025 | 6.40% |
| Jun 30, 2025 | -2.70% |
| Mar 31, 2025 | -10.50% |
| Dec 31, 2024 | 4.78% |
| Sep 30, 2024 | -1.88% |
| Jun 30, 2024 | 2.56% |
| Mar 31, 2024 | 0.08% |
| Dec 31, 2023 | 8.62% |
| Sep 30, 2023 | 3.58% |
| Jun 30, 2023 | 3.34% |
| Mar 31, 2023 | 3.27% |
| Dec 31, 2022 | 17.81% |
| Sep 30, 2022 | 15.36% |
| Jun 30, 2022 | 14.35% |
| Mar 31, 2022 | 9.30% |
| Dec 31, 2021 | 10.32% |
| Sep 30, 2021 | 19.51% |